The sector has accelerated since the onset of the pandemic, which was a tipping point for Indian businesses to realise its true value, says Gartner
Primary issue will be of Rs 5,000 crore, which the company will raise via public issue; OFS by existing investors will be Rs 2,460 crore
Net sales of the company in the period under review stood at Rs 13,611 crore, up 67 per cent
The GRM was impacted by the higher fuel and loss component in view of shutdown, restarting and stabilisation activities at both HPCL refineries
In spite of suffering setbacks in some markets like China and Japan, OYO has been successful in growing its business to more than 157,000 hotels and homestays
Primary issue will be of Rs 5,000 crore, which the company will raise via public issue; OFS by existing investors will be Rs 2,460 crore
Investment will be in Compulsorily Convertible Debentures, which turn into equity based on Sify's operational performance over a specified period
A total of 26.2 million shares have been allocated to over 150 funds at Rs 980 per share
Chairman Ajay Tyagi's tenure ends on Feb 28
In the past, India had extensive discussions with the US on a limited trade deal, with the regime of Donald Trump
During H1FY22, the company disbursed Rs 638 crore registering a growth of 30 per cent year-on-year
Aggregate disbursements in Q2FY22 were up 35% at Rs 8,706 crore, from Rs 6,457 crore in Q2FY21
Brokerages bullish on Nykaa given the firm's high growth potential
As for MSD's drug Molnupiravir, which is currently undergoing clinical trial in India, the company said it has already shared interim data with the drug regulator
India's demand for Digital Talent jobs is currently 8x larger than the available talent pool and is expected to rise to 20x by 2024
Firm is a one-stop clean beauty marketplace focused on non-toxic products; has completed 50,000 orders since inception and currently serves 130,000 online visitors a month
Revenue for Q2 went up 78% to Rs 911 crore from Rs 511 crore during the July-to-September period of 2020-21